Literature DB >> 7665043

Women's health concerns. Is the promotion of hormone replacement therapy for prevention important to women?

F Griffiths1.   

Abstract

The objectives of this study were to find out women's health concerns for the community and for themselves as they age and whether the promotion of hormone replacement therapy for prevention is important to them. A postal questionnaire was sent to 1649 women aged 20-69 years. The sample was random but stratified for age and taken from the lists of eight general practices in the town of Stockton-on-Tees in north east England. The questionnaire included questions on priorities for health care, fears for personal health with ageing, knowledge about osteoporosis, cardiovascular disease and hormone replacement therapy. A 74.3% response rate was achieved. Cancer was named as deserving highest priority for health care in Britain today by 40.7% of respondents. The promotion of long term hormone replacement therapy was given a relatively low priority. The health problem women named as the one they most fear will affect them as they age was, for 30.2% of women, cancer; for 18.8% of women, dementia; for 11.6% of women, arthritis; for 8.8% of women, heart disease. The role of oestrogen in preventing osteoporosis was known by 74.9% of respondents and its role in prevention of cardiovascular disease by 6.6%. Lack of exercise as a risk factor for osteoporosis was known by 29.0% and as a risk factor for cardiovascular disease by 84.6%. Arthritis-like pain was thought to be a warning sign of osteoporosis by by 55.8% of respondents. The promotion of hormone replacement therapy for prevention does not appear to be a high priority for women.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7665043     DOI: 10.1093/fampra/12.1.54

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  5 in total

Review 1.  Alternative treatments for menopausal symptoms. Systematic review of scientific and lay literature.

Authors:  M M Seidl; D E Stewart
Journal:  Can Fam Physician       Date:  1998-06       Impact factor: 3.275

2.  Hormone replacement therapy for all? Universal prescription is desirable.

Authors:  P Toozs-Hobson; L Cardozo
Journal:  BMJ       Date:  1996-08-10

3.  Social and gender variation in the prevalence, presentation and general practitioner provisional diagnosis of chest pain.

Authors:  H Richards; A McConnachie; C Morrison; K Murray; G Watt
Journal:  J Epidemiol Community Health       Date:  2000-09       Impact factor: 3.710

Review 4.  Educating patients about the benefits and drawbacks of hormone replacement therapy.

Authors:  S Rozenberg; J B Vasquez; J Vandromme; M Kroll
Journal:  Drugs Aging       Date:  1998-07       Impact factor: 3.923

5.  Ethnic differences in hormone replacement prescribing patterns.

Authors:  A F Brown; E J Pérez-Stable; E E Whitaker; S F Posner; M Alexander; J Gathe; A E Washington
Journal:  J Gen Intern Med       Date:  1999-11       Impact factor: 5.128

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.